Epilepsy Talk

$112 billion new Alzheimer’s drug in question

July 13, 2021
4 Comments

Getting the FDA to retract a decision is like getting the toothpaste back in the tub, after it’s been squeezed out…

Whether it’s “yes” or “no,” there is no “maybe so”.

A good example is the new all star Alzheimer’s drug aducanumab.


Two Tests Could Aid in Risk Assessment and Early Diagnosis of Alzheimer’s

January 19, 2011
6 Comments

From “The New York Times”, published January 18, 2011…

“Researchers are reporting major advances toward resolving two underlying problems involving Alzheimer’s disease: How do you know if someone who is demented has it? And how can you screen the general population to see who is at risk?…”


    About the author

    Phylis Feiner Johnson

    Phylis Feiner Johnson

    I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

    View Full Profile →

    Enter your email address to follow this blog and receive free notifications of new posts by email.

    Join 3,224 other followers
    Follow Epilepsy Talk on WordPress.com